• You will lead and project manage the implementation of plan onboarding activities, partnering with third-party providers to support specific client needs, primarily within the Group Plan space (e.g., PEPs and MEPs) • You will collaborate with external customers and internal teams to develop and execute effective implementation timelines through both proactive and responsive engagement • You will build, enhance, and maintain strong relationships with client contacts, ensuring overall service requirements and expectations are met • You will serve as a subject matter resource to internal stakeholders on complex implementation solutions that optimize client requirements and drive desired business outcomes • You will develop, maintain, and execute complex onboarding activities that support client service needs while contributing to business objectives, profitability, and client retention within the retirement services organization • You will identify, recommend, and champion process improvements and organizational initiatives to positively influence team performance and quality

Role Description The Associate Director, HEOR Japan will provide execution and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration. - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and ensure the comprehensive plan achieves all needs for Japan. - Evidence Generation & Analysis: Lead or participate in the development of health economic models (cost-effectiveness, budget impact), real-world evidence, burden-of-disease assessments, and outcomes research programs that support regulatory filings, HTA submissions, and reimbursement discussions. - Cross-Functional Collaboration: Partner with Market Access, Medical Affairs, Commercial, Regulatory, and Clinical Development teams to ensure HEOR insights inform decision making across the product lifecycle. - External Engagement: Represent Revolution Medicines in scientific, payer, and HTA forums; engage external stakeholders including key opinion leaders, academic collaborators, HTA bodies, and reimbursement authorities. - Team & Vendor Leadership: Help to lead initiatives both within RevMed and to manage external collaborators (consultants, vendors) to support various HEOR projects within budget and timelines. - Communication: Communicate HEOR strategy, research outcomes, and value propositions to internal leadership (including European and global functions) and external audiences. Qualifications - Advanced degree (PhD, MSc, MPH, or equivalent) in Health Economics, Epidemiology, Pharmacoeconomics, Biostatistics, Public Health, or related discipline. - Demonstrated HEOR experience (>5-7 years) in pharmaceutical/biotech/consulting settings with significant leadership exposure. - Demonstrated success within Japan. - Demonstrated expertise in health economic modeling, RWE study design, outcomes research methodologies, and HTA submission experience. - Strong scientific credibility, strategic vision, and ability to influence cross-functional and external stakeholders. - Excellent communication and leadership skills with experience presenting at scientific and payer forums. - Fluent communication in English. Preferred Skills - Demonstrated ability to drive success through cross-functional teams and external matrices. Company Description Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

• Lead Nerdio's global partnership with Microsoft. • Accountable for the strategy, execution, and measurable outcomes of our joint go-to-market motion with Microsoft worldwide. • Lead a global team of Microsoft Business Development Managers. • Set the direction for co-sell across every Nerdio theater. • Serve as Nerdio's senior representative inside Microsoft's Enterprise, SME&C, Partner, and Marketplace organizations. • Own and evolve Nerdio's worldwide co-sell strategy across the Nerdio product portfolio. • Build and execute joint plays with Microsoft's organizations that drive measurable pipeline and customer acquisition velocity. • Develop and maintain senior relationships across Microsoft's leadership, positioning Nerdio as a preferred co-sell partner. • Define, track, and report on the key performance indicators that matter most.

• Lead the organization’s state and federal policy strategy • Represent the organization to policymakers • Conduct research and policy analysis • Draft briefs, letters, and implement advocacy campaigns • Engage leadership, advisors, members, and partners • Facilitate committees • Track and analyze relevant legislation and regulations • Develop and execute policy strategies aligned with organizational goals